These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tourette syndrome. Neuropsychological tests for obsessive-compulsive disorder and attention deficit hyperactivity disorder. Como PG Neurol Clin; 1997 May; 15(2):255-65. PubMed ID: 9115459 [TBL] [Abstract][Full Text] [Related]
7. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? Goodman WK; McDougle CJ; Price LH; Riddle MA; Pauls DL; Leckman JF J Clin Psychiatry; 1990 Aug; 51 Suppl():36-43; discussion 55-8. PubMed ID: 2199433 [TBL] [Abstract][Full Text] [Related]
8. Obsessive compulsive symptoms in Gilles de la Tourette syndrome and obsessive compulsive disorder: differences by diagnosis and family history. Eapen V; Robertson MM; Alsobrook JP; Pauls DL Am J Med Genet; 1997 Jul; 74(4):432-8. PubMed ID: 9259380 [TBL] [Abstract][Full Text] [Related]
9. [Compulsive disorder and Gilles de la Tourette syndrome. On the differential diagnosis of organic and psychogenic compulsive symptoms]. Müller N; Putz A; Straube A; Kathmann N Nervenarzt; 1995 May; 66(5):372-8. PubMed ID: 7609819 [TBL] [Abstract][Full Text] [Related]
10. Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder. Altemus M; Murphy DL; Greenberg B; Lesch KP Am J Med Genet; 1996 Jul; 67(4):409-11. PubMed ID: 8837711 [TBL] [Abstract][Full Text] [Related]
11. Decreased platelet imipramine binding in Tourette syndrome children with obsessive-compulsive disorder. Weizman A; Mandel A; Barber Y; Weitz R; Cohen A; Mester R; Rehavi M Biol Psychiatry; 1992 Apr; 31(7):705-11. PubMed ID: 1318082 [TBL] [Abstract][Full Text] [Related]